Literature DB >> 25410963

Investigation of the interactions between the EphB2 receptor and SNEW peptide variants.

Buyong Ma1, Stephanie Kolb, Michael Diprima, Molleshree Karna, Giovanna Tosato, Qiqi Yang, Qiang Huang, Ruth Nussinov.   

Abstract

EphB2 interacts with cell surface-bound ephrin ligands to relay bidirectional signals. Overexpression of the EphB2 receptor protein has been linked to different types of cancer. The SNEW (SNEWIQPRLPQH) peptide binds with high selectivity and moderate affinity to EphB2, inhibiting Eph-ephrin interactions by competing with ephrin ligands for the EphB2 high-affinity pocket. We used rigorous free energy perturbation (FEP) calculations to re-evaluate the binding interactions of SNEW peptide with the EphB2 receptor, followed by experimental testing of the computational results. Our results provide insight into dynamic interactions of EphB2 with SNEW peptide. While the first four residues of the SNEW peptide are already highly optimized, change of the C-terminal end of the peptide has the potential to improve SNEW-binding affinity. We identified a PXSPY motif that can be similarly aligned with several other EphB2-binding peptides.

Entities:  

Keywords:  EphB2 receptor; ephrin ligands; inhibitor design; molecular dynamics simulations; protein dynamics; protein stability

Mesh:

Substances:

Year:  2014        PMID: 25410963      PMCID: PMC4627370          DOI: 10.3109/08977194.2014.985786

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  46 in total

Review 1.  Targeting Eph receptors with peptides and small molecules: progress and challenges.

Authors:  Roberta Noberini; Ilaria Lamberto; Elena B Pasquale
Journal:  Semin Cell Dev Biol       Date:  2011-10-25       Impact factor: 7.727

2.  A change in conformational dynamics underlies the activation of Eph receptor tyrosine kinases.

Authors:  Silke Wiesner; Leanne E Wybenga-Groot; Neil Warner; Hong Lin; Tony Pawson; Julie D Forman-Kay; Frank Sicheri
Journal:  EMBO J       Date:  2006-09-14       Impact factor: 11.598

Review 3.  Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis.

Authors:  Ombretta Salvucci; Giovanna Tosato
Journal:  Adv Cancer Res       Date:  2012       Impact factor: 6.242

4.  Analysis of EphA4 receptor tyrosine kinase substrate specificity using peptide-based arrays.

Authors:  Neil Warner; Leanne E Wybenga-Groot; Tony Pawson
Journal:  FEBS J       Date:  2008-04-15       Impact factor: 5.542

5.  Manipulation of EphB2 regulatory motifs and SH2 binding sites switches MAPK signaling and biological activity.

Authors:  Jiefei Tong; Sabine Elowe; Piers Nash; Tony Pawson
Journal:  J Biol Chem       Date:  2002-12-16       Impact factor: 5.157

Review 6.  Ephs and ephrins in cancer: ephrin-A1 signalling.

Authors:  Amanda Beauchamp; Waldemar Debinski
Journal:  Semin Cell Dev Biol       Date:  2011-10-25       Impact factor: 7.727

7.  The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma.

Authors:  Qinghua Wu; Zhenhe Suo; Gunnar B Kristensen; Mark Baekelandt; Jahn M Nesland
Journal:  Gynecol Oncol       Date:  2006-02-23       Impact factor: 5.482

8.  An efficient bioorthogonal strategy using CuAAC click chemistry for radiofluorinations of SNEW peptides and the role of copper depletion.

Authors:  Marc Pretze; Manuela Kuchar; Ralf Bergmann; Jörg Steinbach; Jens Pietzsch; Constantin Mamat
Journal:  ChemMedChem       Date:  2013-04-04       Impact factor: 3.466

9.  PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity.

Authors:  Roberta Noberini; Sayantan Mitra; Ombretta Salvucci; Fatima Valencia; Srinivas Duggineni; Natalie Prigozhina; Ke Wei; Giovanna Tosato; Ziwei Huang; Elena B Pasquale
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

10.  Structural plasticity of eph receptor A4 facilitates cross-class ephrin signaling.

Authors:  Thomas A Bowden; A Radu Aricescu; Joanne E Nettleship; Christian Siebold; Nahid Rahman-Huq; Raymond J Owens; David I Stuart; E Yvonne Jones
Journal:  Structure       Date:  2009-10-14       Impact factor: 5.006

View more
  1 in total

Review 1.  Targeting the Eph System with Peptides and Peptide Conjugates.

Authors:  Stefan J Riedl; Elena B Pasquale
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.